Key Takeaways from ASCO 2019 - Digesting the new data with a Key Opinion LeaderTicker(s): AMGN, MRK, IOVA, NKTR, NVS, AZN, MRTX, BPMC
Name: Dr Foluso Ademuyiwa - MD
- Medical oncologist at Washington University in St. Louis whose research focuses on developing novel treatments for patients with triple negative breast cancer (TNBC).
- Treats ~150 patients with HER2-positive breast cancer (total) & 15 patients with triple negative breast cancer per week.
- Principal Investigator on an NIH-funded clinical trial investigating a unique chemotherapy combination in the pre-operative setting in patients with TNBC.
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.